Kei S. Tolliver
Oprichter bij VLP Therapeutics LLC
Profiel
Kei S.
Tolliver is the founder of VLP Therapeutics LLC, which was founded in 2012, where she holds the title of General Counsel.
Ms. Tolliver's former jobs include Director-Business Development at S&R Technology Holdings LLC from 2002 to 2013, Director at Sucampo Pharmaceuticals, Inc. in 2013-2014, Director & General Manager at Sucampo Pharma Europe Ltd., Director at Sucampo Pharma LLC, and VP-Operations & Business Development at Sucampo Pharmaceuticals, Inc. from 1998 to 2008.
Ms. Tolliver's education history includes an undergraduate degree from West Virginia University and a graduate degree from Columbus School of Law.
Actieve functies van Kei S. Tolliver
Bedrijven | Functie | Begin |
---|---|---|
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | Oprichter | 01-01-2012 |
Eerdere bekende functies van Kei S. Tolliver
Bedrijven | Functie | Einde |
---|---|---|
SUCAMPO PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-12-2014 |
SUCAMPO PHARMACEUTICALS, INC. | Operationeel Directeur | 31-05-2008 |
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Directeur/Bestuurslid | - |
Sucampo Pharma LLC
Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan. | Directeur/Bestuurslid | - |
S&R Technology Holdings LLC
S&R Technology Holdings LLC Financial ConglomeratesFinance S&R Technology Holdings LLC provide support to global entrepreneurs and new businesses. It offers managing and growing global ventures. The company was founded by Sachiko Kuno and Ryuji Ueno in 1999 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Opleiding van Kei S. Tolliver
West Virginia University | Undergraduate Degree |
Columbus School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
S&R Technology Holdings LLC
S&R Technology Holdings LLC Financial ConglomeratesFinance S&R Technology Holdings LLC provide support to global entrepreneurs and new businesses. It offers managing and growing global ventures. The company was founded by Sachiko Kuno and Ryuji Ueno in 1999 and is headquartered in Bethesda, MD. | Finance |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
Sucampo Pharma Europe Ltd.
Sucampo Pharma Europe Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Mallinckrodt Plc, Sucampo Pharma Europe Ltd. is a British company that develops therapies for gastrointestinal, circulatory, and ophthalmic diseases. The company is based in London, UK. Sucampo Pharma Europe was acquired by Sucampo Pharmaceuticals LLC, part of Mallinckrodt Plc from February 14, 2018 on September 28, 2006. | Commercial Services |
Sucampo Pharma LLC
Sucampo Pharma LLC Miscellaneous Commercial ServicesCommercial Services Sucampo Pharma LLC engages in the pharmaceutical product development. It develops the naturally occurring compound prostones, including lubiprostone under the brand Amitiza, which is used for the treatment of chronic constipation, chronic idiopathic constipation (CIC) in adults, and irritable bowel syndrome with constipation (IBS-C). The company is headquartered in Osaka, Japan. | Commercial Services |
VLP Therapeutics LLC
VLP Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services VLP Therapeutics LLC operates as a biopharmaceutical company. The firm focuses on developing preventative and therapeutic vaccines, as well as next generation targeted antibody agents to treat cancer and infectious diseases, such as malaria, dengue fever, zika virus-based diseases, and autoimmune. The company was founded by Wataru Akahata, Ryuji Ueno, Sachiko Kuno, Kei S. Tolliver and Misako Nakata in 2012 and is headquartered in Gaithersburg, MD. | Commercial Services |